Down-regulation of ABCE1 inhibits temozolomide resistance in glioma through the PI3K/Akt/NF-κB signaling pathway
Authors:
Open Access
- 11 December 2018
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 38 (6)
Abstract
The ATP binding cassette (ABC) E1 (ABCE1), a member of the ABC family, was originally described as the RNase L inhibitor. Through forming a heterodimer with RNase L, ABCE1 participates in the negative regulation of the 2-5A/RNase L system and thus mediates a wide range of biological functions. Recent evidence has shown the new roles of ABCE1 in tumorigenesis. However, there have been no investigations on the specific effect of ABCE1 on glioma. In the present study, we examined the expression pattern and possible role of ABCE1 in glioma. Our study demonstrated that ABCE1 was up-regulated in glioma tissues and cell lines. Down-regulation of ABCE1 inhibited temozolomide (TMZ) resistance of glioma cells in vitro and in vivo. In addition, we found that the PI3K/Akt/NF-κB pathway was involved in ABCE1-mediated chemoresistance of glioma cells. Taken together, our study suggested ABCE1 as a promising target for glioma chemotherapy.Keywords
This publication has 53 references indexed in Scilit:
- Targeting the NF-κB Pathway in Cancer TherapySurgical Oncology Clinics of North America, 2013
- Silencing of MicroRNA-21 Confers Radio-Sensitivity through Inhibition of the PI3K/AKT Pathway and Enhancing Autophagy in Malignant Glioma Cell LinesPLOS ONE, 2012
- Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude miceOncology Letters, 2012
- MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human gliomaInternational Journal of Oncology, 2011
- The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell‐mediated VEGF production and tumour angiogenesis via PI3K/AKT signallingThe Journal of Pathology, 2011
- Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomideNeuro-Oncology, 2011
- Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like CellsCell Stem Cell, 2009
- Hexamethylene Bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF-κB activity: Implications for cancer therapyCell Cycle, 2008